• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for Utilization of Biochemical Markers in Acute Coronary Syndromes and Heart Failure.

作者信息

Christenson Robert H

机构信息

National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for Utilization of Biochemical Markers in Acute Coronary Syndromes and Heart Failure, University of Maryland School of Medicine, Baltimore, MD, USA.

出版信息

Clin Chem. 2007 Apr;53(4):545-6. doi: 10.1373/clinchem.2006.079749. Epub 2007 Mar 23.

DOI:10.1373/clinchem.2006.079749
PMID:17384002
Abstract
摘要

相似文献

1
National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for Utilization of Biochemical Markers in Acute Coronary Syndromes and Heart Failure.美国国家临床生物化学学会实验室医学实践指南：急性冠状动脉综合征和心力衰竭中生化标志物的应用
Clin Chem. 2007 Apr;53(4):545-6. doi: 10.1373/clinchem.2006.079749. Epub 2007 Mar 23.
2
National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: clinical characteristics and utilization of biochemical markers in acute coronary syndromes.美国国家临床生物化学学会实验室医学实践指南：急性冠状动脉综合征中生化标志物的临床特征及应用
Clin Chem. 2007 Apr;53(4):552-74. doi: 10.1373/clinchem.2006.084194. Epub 2007 Mar 23.
3
National Academy of Clinical Biochemistry and IFCC Committee for Standardization of Markers of Cardiac Damage Laboratory Medicine Practice Guidelines: analytical issues for biochemical markers of acute coronary syndromes.美国国家临床生物化学学会和国际临床化学与检验医学联合会心脏损伤标志物标准化委员会实验室医学实践指南：急性冠状动脉综合征生化标志物的分析问题
Clin Chem. 2007 Apr;53(4):547-51. doi: 10.1373/clinchem.2006.084715. Epub 2007 Mar 23.
4
Preamble: National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for utilization of biomarkers in acute coronary syndromes and heart failure.
Clin Biochem. 2008 Mar;41(4-5):208-9. doi: 10.1016/j.clinbiochem.2007.07.003. Epub 2007 Aug 31.
5
National Academy of Clinical Biochemistry Standards of Laboratory Practice: recommendations for the use of cardiac markers in coronary artery diseases.国家临床生物化学学会实验室操作标准：冠状动脉疾病中心脏标志物使用的建议
Clin Chem. 1999 Jul;45(7):1104-21.
6
National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: Clinical characteristics and utilization of biochemical markers in acute coronary syndromes.美国国家临床生物化学学会实验室医学实践指南：急性冠状动脉综合征中生化标志物的临床特征与应用
Circulation. 2007 Apr 3;115(13):e356-75. doi: 10.1161/CIRCULATIONAHA.107.182882. Epub 2007 Mar 23.
7
[The use of guidelines for the diagnosis of acute coronary syndromes in the emergency department. Report of the American Heart Association].[急诊科急性冠状动脉综合征诊断指南的应用。美国心脏协会报告]
Recenti Prog Med. 2005 Nov;96(11):586-7.
8
National Academy of Clinical Biochemistry and IFCC Committee for Standardization of Markers of Cardiac Damage Laboratory Medicine Practice Guidelines: Analytical issues for biochemical markers of acute coronary syndromes.美国国家临床生物化学学会和国际临床化学与检验医学联合会心脏损伤标志物标准化委员会实验室医学实践指南：急性冠状动脉综合征生化标志物的分析问题
Circulation. 2007 Apr 3;115(13):e352-5. doi: 10.1161/CIRCULATIONAHA.107.182881. Epub 2007 Mar 23.
9
National Academy of Clinical Biochemistry laboratory medicine practice guidelines: use of cardiac troponin and B-type natriuretic peptide or N-terminal proB-type natriuretic peptide for etiologies other than acute coronary syndromes and heart failure.美国国家临床生物化学学会实验室医学实践指南：心肌肌钙蛋白和B型利钠肽或N末端B型利钠肽原在急性冠状动脉综合征和心力衰竭以外病因中的应用
Clin Chem. 2007 Dec;53(12):2086-96. doi: 10.1373/clinchem.2007.095679. Epub 2007 Oct 22.
10
Guidelines for the diagnosis and treatment of non-ST segment elevation acute coronary syndromes.非ST段抬高型急性冠状动脉综合征诊断和治疗指南
Eur Heart J. 2008 Jan;29(2):277. doi: 10.1093/eurheartj/ehm439. Epub 2007 Oct 5.

引用本文的文献

1
Uncovering key biomarkers, potential therapeutic targets and development of deep learning model in heart failure.揭示心力衰竭中的关键生物标志物、潜在治疗靶点及深度学习模型的开发。
PLoS One. 2025 Sep 3;20(9):e0330780. doi: 10.1371/journal.pone.0330780. eCollection 2025.
2
Identification of potential M2 macrophage-associated diagnostic biomarkers in coronary artery disease.冠心病中潜在 M2 巨噬细胞相关诊断生物标志物的鉴定。
Biosci Rep. 2022 Dec 22;42(12). doi: 10.1042/BSR20221394.
3
Biomarkers-based personalized follow-up in chronic heart failure improves patient's outcomes and reduces care associate cost.
基于生物标志物的慢性心力衰竭个体化随访可改善患者结局并降低相关医疗成本。
Health Qual Life Outcomes. 2021 May 8;19(1):142. doi: 10.1186/s12955-021-01779-9.
4
Construction and analysis of a joint diagnosis model of random forest and artificial neural network for heart failure.构建并分析基于随机森林和人工神经网络的心力衰竭联合诊断模型。
Aging (Albany NY). 2020 Dec 26;12(24):26221-26235. doi: 10.18632/aging.202405.
5
The Importance of Serial Time Point Quantitative Assessment of Cardiac Troponin I in the Diagnosis of Acute Myocardial Damage.肌钙蛋白I连续时间点定量评估在急性心肌损伤诊断中的重要性
Indian J Crit Care Med. 2018 Sep;22(9):629-631. doi: 10.4103/ijccm.IJCCM_8_16.
6
Defining the Path Forward: Guidance for Laboratory Medicine Guidelines.明确前进方向：检验医学指南指南
EJIFCC. 2015 Aug 24;26(3):158-67. eCollection 2015 Aug.
7
An Evaluation of Laboratory Efficiency in Shanghai Emergency by Turn Around Times Level.基于周转时间水平对上海急诊实验室效率的评估。
J Clin Lab Anal. 2015 Jul;29(4):334-41. doi: 10.1002/jcla.21775. Epub 2014 Aug 17.
8
Prognostic effect size of cardiovascular biomarkers in datasets from observational studies versus randomised trials: meta-epidemiology study.观察性研究与随机试验数据集中心血管生物标志物预后效应大小的Meta 流行病学研究。
BMJ. 2011 Nov 7;343:d6829. doi: 10.1136/bmj.d6829.
9
National Academy of Clinical Biochemistry (NACB) laboratory medicine guidelines on the clinical utilization and analytical issues for cardiac biomarker testing in heart failure.美国国家临床生物化学学会（NACB）关于心力衰竭患者心脏生物标志物检测的临床应用及分析问题的检验医学指南。
Clin Biochem Rev. 2008 Aug;29(3):107-11.